Cyclopropane indolinone derivatives
US8354443B2 · kind B2 · utility
2Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2010 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Jan 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of formula (I)as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 have the significance given in claim 1. The compound may be used, for example, for the treatment or prophylaxis of obesity, hyperglycemia, dyslipidemia, and type 1 or type 2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.